Neoadjuvant paclitaxel, ifosfamide, and cisplatin chemotherapy for metastatic penile cancer: A phase II study

Journal of Clinical Oncology

Volumn 28, Issue 24, 2010, Pages 3851-3857

  Pagliaro, Lance C ^a   Williams, Dallas L ^a   Daliani, Danai ^a   Williams, Michael B ^a   Osai, William ^a   Kincaid, Michael ^a   Wen, Sijin ^a   Thall, Peter F ^a   Pettaway, Curtis A ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CIMETIDINE; CISPLATIN; DEXAMETHASONE; DIPHENHYDRAMINE; FAMOTIDINE; GRANULOCYTE COLONY STIMULATING FACTOR; IFOSFAMIDE; MESNA; PACLITAXEL; RANITIDINE; ANTINEOPLASTIC AGENT;

ADULT; AGED; ALLERGIC REACTION; ANEMIA; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CATHETER THROMBOSIS; CLINICAL ASSESSMENT; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; FEBRILE NEUTROPENIA; FOLLOW UP; HEART MUSCLE ISCHEMIA; HISTOPATHOLOGY; HUMAN; HYPERGLYCEMIA; INFECTION; LYMPH NODE METASTASIS; LYMPHADENOPATHY; MALE; METASTASIS; MOTOR NEUROPATHY; NEUTROPENIA; OVERALL SURVIVAL; PENIS CANCER; PHASE 2 CLINICAL TRIAL; POSTOPERATIVE CARE; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; SKIN METASTASIS; SQUAMOUS CELL CARCINOMA; STATISTICAL SIGNIFICANCE; SURGICAL APPROACH; SURGICAL TECHNIQUE; THROMBOCYTOPENIA; ADJUVANT CHEMOTHERAPY; ADJUVANT THERAPY; CLINICAL TRIAL; DISEASE FREE SURVIVAL; DRUG ADMINISTRATION; KAPLAN MEIER METHOD; LYMPHADENECTOMY; METHODOLOGY; MIDDLE AGED; PATHOLOGY; PENIS TUMOR; PREDICTION AND FORECASTING; PROSPECTIVE STUDY; RISK FACTOR; TREATMENT OUTCOME;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, SQUAMOUS CELL; CHEMOTHERAPY, ADJUVANT; CISPLATIN; DISEASE-FREE SURVIVAL; DRUG ADMINISTRATION SCHEDULE; HUMANS; IFOSFAMIDE; KAPLAN-MEIERS ESTIMATE; LYMPH NODE EXCISION; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOADJUVANT THERAPY; NEOPLASM STAGING; PACLITAXEL; PENILE NEOPLASMS; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; RADIOTHERAPY, ADJUVANT; RISK FACTORS; TREATMENT OUTCOME;

EID: 77956233851     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2010.29.5477     Document Type: Article

References (28)

1. Jemal A, Siegel R, Ward E, et al: Cancer statistics, 2009. CA Cancer J Clin 59:225-249, 2009
2. Misra S, Chaturvedi A, Misra NC: Penile carcinoma: A challenge for the developing world. Lancet Oncol 5:240-247, 2004 (Pubitemid 38391219)
3. Bleeker MC, Heideman DA, Snijders PJ, et al: Penile cancer: Epidemiology, pathogenesis and prevention. World J Urol 27:141-150, 2009
4. Epidermoid anal cancer: Results from the UKCCCR randomised trial of radiotherapy alone versus radiotherapy, 5-fluorouracil, and mitomycin - UKCCCR Anal Cancer Trial Working Party, UK Coordinating Committee on Cancer Research. Lancet 348:1049-1054, 1996
5. Montana GS, Thomas GM, Moore DH, et al: Preoperative chemo-radiation for carcinoma of the vulva with N2/N3 nodes: A Gynecologic Oncology Group study. Int J Radiat Oncol Biol Phys 48:1007-1013, 2000
6. Winquist E, Oliver T, Gilbert R: Postoperative chemoradiotherapy for advanced squamous cell carcinoma of the head and neck: A systematic review with meta-analysis. Head Neck 29:38-46, 2007 (Pubitemid 46032565)
7. de Kernion JB, Tynberg P, Persky L, et al: Proceedings: Carcinoma of the penis. Cancer 32: 1256-1262, 1973
8. Horenblas S, van Tinteren H, Delemarre JF, et al: Squamous cell carcinoma of the penis: III. Treatment of regional lymph nodes. J Urol 149:492-497, 1993 (Pubitemid 23094037)
9. Ravi R: Correlation between the extent of nodal involvement and survival following groin dissection for carcinoma of the penis. Br J Urol 72:817-819, 1993
10. Haas GP, Blumenstein BA, Gagliano RG, et al: Cisplatin, methotrexate and bleomycin for the treatment of carcinoma of the penis: A Southwest Oncology Group study. J Urol 161:1823-1825, 1999
11. Pizzocaro G, Piva L: Adjuvant and neoadjuvant vincristine, bleomycin, and methotrexate for inguinal metastases from squamous cell carcinoma of the penis. Acta Oncol 27:823-824, 1988
12. Leijte JA, Kerst JM, Bais E, et al: Neoadjuvant chemotherapy in advanced penile carcinoma. Eur Urol 52:488-494, 2007 (Pubitemid 46963441)
13. Bermejo C, Busby JE, Spiess PE, et al: Neoadjuvant chemotherapy followed by aggressive surgical consolidation for metastatic penile squamous cell carcinoma. J Urol 177:1335-1338, 2007 (Pubitemid 46435966)
14. Novara G, Galfano A, De Marco V, et al: Prognostic factors in squamous cell carcinoma of the penis. Nat Clin Pract Urol 4:140-146, 2007 (Pubitemid 46416278)
15. Pandey D, Mahajan V, Kannan RR: Prognostic factors in node-positive carcinoma of the penis. J Surg Oncol 93:133-138, 2006 (Pubitemid 43235259)
16. Lont AP, Kroon BK, Gallee MP, et al: Pelvic lymph node dissection for penile carcinoma: Extent of inguinal lymph node involvement as an indicator for pelvic lymph node involvement and survival. J Urol 177:947-952, 2007 (Pubitemid 46216348)
17. Crook J, Ma C, Grimard L: Radiation therapy in the management of the primary penile tumor: An update. World J Urol 27:189-196, 2009
18. Theodore C, Skoneczna I, Bodrogi I, et al: A phase II multicentre study of irinotecan (CPT 11) in combination with cisplatin (CDDP) in metastatic or locally advanced penile carcinoma (EORTC Protocol 30992). Ann Oncol 19:1304-1307, 2008
19. Shin DM, Glisson BS, Khuri FR, et al: Phase II trial of paclitaxel, ifosfamide, and cisplatin in patients with recurrent head and neck squamous cell carcinoma. J Clin Oncol 16:1325-1330, 1998 (Pubitemid 28175747)
20. Greene F, Page DL, Fleming ID, et al: AJCC Cancer Staging Manual (ed 6). New York, NY, Springer, 2002
21. Therasse P, Arbuck SG, Eisenhauer EA, et al: New guidelines to evaluate the response to treatment in solid tumors: European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. J Natl Cancer Inst 92:205-216, 2000
22. National Cancer Institute Cancer Therapy Evaluation Program: Common Terminology Criteria for Adverse Events v3.0 (CTCAE). http://ctep.cancer.gov/ protocoldevelopment/electronic-applications/docs/ctcaev3.pdf
23. Bevan-Thomas R, Slaton JW, Pettaway CA: Contemporary morbidity from lymphadenectomy for penile squamous cell carcinoma: The M.D. Anderson Cancer Center Experience. J Urol 167:1638-1642, 2002 (Pubitemid 34240689)
24. Thall PF, Sung HG: Some extensions and applications of a Bayesian strategy for monitoring multiple outcomes in clinical trials. Stat Med 17: 1563-1580, 1998 (Pubitemid 28367838)
25. Kaplan EL, Meier P: Nonparametric estimation from incomplete observations. J Am Stat Assoc 53:457-481, 1958
26. Mantel N: Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep 50:163-170, 1966
27. Srinivas V, Morse MJ, Herr HW, et al: Penile cancer: Relation of extent of nodal metastasis to survival. J Urol 137:880-882, 1987 (Pubitemid 17074883)
28. Lopes A, Hidalgo GS, Kowalski LP, et al: Prognostic factors in carcinoma of the penis: Multivariate analysis of 145 patients treated with amputation and lymphadenectomy. J Urol 156:1637-1642, 1996 (Pubitemid 26344009)